Germany
· Delayed Price · Currency is EUR Coloplast Statistics
Total Valuation
Coloplast has a market cap or net worth of EUR 24.06 billion. The enterprise value is 26.98 billion.
| Market Cap | 24.06B |
| Enterprise Value | 26.98B |
Important Dates
The next estimated earnings date is Tuesday, February 4, 2025.
| Earnings Date | Feb 4, 2025 |
| Ex-Dividend Date | Dec 6, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.36% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 141.36M |
Valuation Ratios
The trailing PE ratio is 35.51.
| PE Ratio | 35.51 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.75, with an EV/FCF ratio of 125.77.
| EV / Earnings | 39.83 |
| EV / Sales | 7.45 |
| EV / EBITDA | 23.75 |
| EV / EBIT | 27.54 |
| EV / FCF | 125.77 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 1.26.
| Current Ratio | 1.02 |
| Quick Ratio | 0.62 |
| Debt / Equity | 1.26 |
| Debt / EBITDA | 2.67 |
| Debt / FCF | 14.14 |
| Interest Coverage | 9.19 |
Financial Efficiency
Return on equity (ROE) is 28.67% and return on invested capital (ROIC) is 11.80%.
| Return on Equity (ROE) | 28.67% |
| Return on Assets (ROA) | 9.49% |
| Return on Capital (ROIC) | 11.80% |
| Revenue Per Employee | 217,842 |
| Profits Per Employee | 40,715 |
| Employee Count | 16,639 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 2.44 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.08% in the last 52 weeks. The beta is 0.33, so Coloplast's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +2.08% |
| 50-Day Moving Average | 117.92 |
| 200-Day Moving Average | 118.20 |
| Relative Strength Index (RSI) | 36.19 |
| Average Volume (20 Days) | 334 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Coloplast had revenue of EUR 3.62 billion and earned 677.46 million in profits. Earnings per share was 3.01.
| Revenue | 3.62B |
| Gross Profit | 2.45B |
| Operating Income | 980.12M |
| Pretax Income | 857.56M |
| Net Income | 677.46M |
| EBITDA | 1.10B |
| EBIT | 980.12M |
| Earnings Per Share (EPS) | 3.01 |
Balance Sheet
The company has 105.67 million in cash and 3.03 billion in debt, giving a net cash position of -2.93 billion.
| Cash & Cash Equivalents | 105.67M |
| Total Debt | 3.03B |
| Net Cash | -2.93B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.41B |
| Book Value Per Share | 10.69 |
| Working Capital | 32.18M |
Cash Flow
In the last 12 months, operating cash flow was 370.92 million and capital expenditures -156.36 million, giving a free cash flow of 214.56 million.
| Operating Cash Flow | 370.92M |
| Capital Expenditures | -156.36M |
| Free Cash Flow | 214.56M |
| FCF Per Share | n/a |
Margins
Gross margin is 67.59%, with operating and profit margins of 27.04% and 18.69%.
| Gross Margin | 67.59% |
| Operating Margin | 27.04% |
| Pretax Margin | 23.66% |
| Profit Margin | 18.69% |
| EBITDA Margin | 30.30% |
| EBIT Margin | 27.04% |
| FCF Margin | 5.92% |
Dividends & Yields
This stock pays an annual dividend of 2.95, which amounts to a dividend yield of 2.75%.
| Dividend Per Share | 2.95 |
| Dividend Yield | 2.75% |
| Dividend Growth (YoY) | 4.69% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 93.43% |
| Buyback Yield | -4.36% |
| Shareholder Yield | -1.61% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Coloplast has an Altman Z-Score of 5.4.
| Altman Z-Score | 5.4 |
| Piotroski F-Score | n/a |